India’s primary market is preparing for a busy week, with Jio Platforms and Paras Healthcare scheduled in market reports to open their initial public offerings (IPOs) on October 21, 2026. Investors considering either issue should read the final offer documents carefully, compare valuations and understand the risks rather than relying only on headlines or unofficial grey-market premium (GMP) quotes.
Jio Platforms IPO: key reported details
Recent reports say Jio Platforms’ IPO is scheduled to open from October 21 to October 23, with a reported price band of ₹1,065 to ₹1,119 per share. The offer is expected to be a major issue for India’s markets, and reporting on the updated prospectus says the company plans a fresh issue of shares. The prospectus provides important details on the business, risks, use of proceeds and ownership structure.
Investors should confirm the final issue size, lot size, reservation categories, application cut-off and dates directly from the published offer documents and exchange notices. Do not use an older article as the only source, particularly if the company issues a corrigendum or changes a detail.
Paras Healthcare IPO: dates and price band
Economic Times reporting published on October 18 says Paras Healthcare’s offer is scheduled to run from October 21 to October 23, with a reported price band of ₹660 to ₹693 per share. Before applying, readers should verify the issue size, lot size, minimum application amount and reservation details in the company’s final offer documents.
What about grey-market premium (GMP)?
GMP is an unofficial indication quoted outside the regulated exchange process. It can change rapidly, may come from sources that are difficult to verify, and does not guarantee the listing price or an investor’s return. A high quoted premium should not replace analysis of revenue, profitability, debt, cash flow, valuation, industry conditions and the risk factors disclosed by the issuer.
How should investors evaluate an IPO?
Read the red herring prospectus, review the company’s financial statements and use-of-proceeds section, and understand the difference between fresh issue shares and an offer for sale. Compare valuation multiples with listed peers where appropriate. Consider your own risk tolerance and avoid borrowing money purely to apply for a popular issue.
IPO applications are subject to allotment and market risk. Even well-known brands can list below their issue price if sentiment or valuations change. Investors should also be wary of messages promising guaranteed allotment or fixed listing gains.
Bottom line: Both offers are reported for October 21–23, but confirm final details through official IPO documents and exchange notices. GMP is speculative and should never be presented as a guaranteed outcome.
